Billings Clinic
Especially For:

Clinical Trials

Title   Melanoma:M101b' Ziopharm Stage III-IV MALIGNANT UNRESECTABLE
Description   Phase 1b' Open Label, Single Arm, Multicenter Trial to Evaluate the Safety, Tolerance, Response Rate and Immunological Effects of Repeated Intratumoral Injections of Adenoviral Transduced Autologous Denditric Cells Engineered to Express hIL-12(INXN-3001) in Response to an Oral Activator Ligand in Patients With Unresectable Stage III C or IV Malignant Melanoma
IRB Number   0000
Category   Melanoma
Inclusion/Notes   * must be at least 18 years old to participate
* no central nervous system involvement or other types of cancers
* patient must be seen at the Billings Clinic

Status   open
Start Date   08/06/2010
Principal Investigator (PI)   Jorge Nieva, MD
Physician Profile   Medical Oncologist
Contact Name   Kate Reed
Contact Email   kreed@billingsclinic.org
Phone   (406) 435-7444
Fax   (406) 435-7489
Funding Source   NCI
Print This Page
Email to a Friend
Home | Contact | Site Map | Site Privacy Policy | Terms & Conditions | Patient Privacy Policy | Medical Records | Fast Command
2800 10th Ave. North | P.O. Box 37000 | Billings, Montana 59107 | 406.238.2500
© Copyright 2014 Billings Clinic. All Rights Reserved.